Apteki 36 (Russia) Today
APTK Stock | 14.43 0.09 0.62% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Apteki 36 is trading at 14.43 as of the 17th of April 2024, a -0.62 percent decrease since the beginning of the trading day. The stock's open price was 14.52. Apteki 36 has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Apteki 36 are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 18th of March 2024 and ending today, the 17th of April 2024. Click here to learn more.
Moving against Apteki Stock
0.48 | SBER | Sberbank Rossii PAO | PairCorr |
0.44 | SNGSP | Surgut pref | PairCorr |
Apteki 36 cannot be verified against its exchange. It appears that Apteki 36 is not available for investing at the moment. Please verify the symbol is currently traded on MICEX Moscow Russia. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshApteki Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Apteki 36's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Apteki 36 or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business Concentration | Pharmaceutical Retailers, Healthcare (View all Sectors) |
Apteki 36 (APTK) is traded on MICEX Moscow Russia in Russia and employs 10 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 95.35 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Apteki 36's market, we take the total number of its shares issued and multiply it by Apteki 36's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Apteki 36 operates under Healthcare sector and is part of Pharmaceutical Retailers industry. The entity has 7.63 B outstanding shares.
Apteki 36 has accumulated about 118 M in cash with (3.37 B) of positive cash flow from operations.
Check Apteki 36 Probability Of Bankruptcy
Apteki 36 Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Apteki 36 market risk premium is the additional return an investor will receive from holding Apteki 36 long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Apteki 36. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Apteki 36's alpha and beta are two of the key measurements used to evaluate Apteki 36's performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 1.47 | |||
Semi Deviation | 1.99 | |||
Standard Deviation | 3.11 | |||
Variance | 9.7 |
Apteki Stock Against Markets
Picking the right benchmark for Apteki 36 stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Apteki 36 stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Apteki 36 is critical whether you are bullish or bearish towards Apteki 36 at a given time. Please also check how Apteki 36's historical prices are related to one of the top price index indicators.
Try Other Suggestions
Be your own money manager
Our tools can tell you how much better you can do entering a position in Apteki 36 without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
All Next | Launch Module |
Apteki 36 Corporate Management
Elected by the shareholders, the Apteki 36's board of directors comprises two types of representatives: Apteki 36 inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Apteki. The board's role is to monitor Apteki 36's management team and ensure that shareholders' interests are well served. Apteki 36's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Apteki 36's outside directors are responsible for providing unbiased perspectives on the board's policies.
Bicherkharov Ramazanovich | Member Board | Profile | |
Gusarov Igorevich | Director Board | Profile | |
Alexander Kuzin | Chief Officer | Profile | |
Ruslan Nasybullin | Chief Officer | Profile | |
Vladimir Kintsurashvili | Chairman Board | Profile | |
Deryabina Anatolyevna | Member Board | Profile | |
Ivan Saganelidze | First Director | Profile |
How to buy Apteki Stock?
Before investing in Apteki 36, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Apteki 36. To buy Apteki 36 stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Apteki 36. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Apteki 36 stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Apteki 36 stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Apteki 36 stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Apteki 36, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Apteki 36?
The danger of trading Apteki 36 is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Apteki 36 is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Apteki 36. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Apteki 36 is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apteki 36. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Apteki Stock analysis
When running Apteki 36's price analysis, check to measure Apteki 36's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apteki 36 is operating at the current time. Most of Apteki 36's value examination focuses on studying past and present price action to predict the probability of Apteki 36's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apteki 36's price. Additionally, you may evaluate how the addition of Apteki 36 to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |